Table 3:
Hyperlipidemia Patients Attaining Goal Levels of Low Density Lipoprotein (LDL), by Demographics and Clinic Site. University of California San Diego Student-Run Free Clinic Project From August 2006–November 2010*
| Patient Characteristic | n (%) At LDL Goal |
Unadjusted Analysis1 | |
|---|---|---|---|
| OR (95% CI) | P Value2 | ||
| Overall | 56 (58.3) | ||
| Age (per year) | NA | 1.03 (0.99, 1.08) | .16 |
| Gender, n (%) | .54 | ||
| Female | 31 (62.0) | 1 | |
| Male | 25 (54.3) | 0.73 (0.32, 1.65) | |
| Ethnicity, n (%) | .0453 | ||
| Hispanic | 34 (65.4) | 1 | |
| Caucasian | 14 (42.4) | 0.39 (0.16, 0.96) | |
| Asian | 2 (50.0) | 0.53 (0.07, 4.08) | |
| Black | 3 (100) | Inf (0, Inf) | |
| Other | 3 (75.0) | 1.59 (0.15, 16.4) | |
| Site, n (%) | 1.0 | ||
| Downtown | 25 (58.1) | 1 | |
| Mountain View | 18 (60.0) | 1.08 (0.42, 2.79) | |
| Pacific Beach | 13 (56.5) | 0.94 (0.34, 2.60) | |
| Risk category, n (%) | .91 | ||
| Very high risk | 2 (40.0) | 0.47 (0.07, 2.98) | |
| High risk | 40 (58.8) | 1 | |
| Moderate risk | 11 (61.1) | 1.10 (0.38, 3.19) | |
| Low risk | 3 (60.0) | 1.05 (0.17, 6.70) | |
| DM2 comorbidity, n (%) | .64 | ||
| HL only | 13 (54.2) | 1 | |
| HL and DM2 | 43 (59.7) | 1.26 (0.50, 3.18) | |
| Housing status, n (%) | 1.0 | ||
| Housed | 48 (57.8) | 1 | |
| Homeless | 8 (61.5) | 1.17 (0.35, 3.87) | |
| Primary language, n (%) | .30 | ||
| English | 27 (52.9) | 1 | |
| Spanish | 29 (64.4) | 1.16 (0.71, 3.66) | |
| LDL control at baseline, n (%) | 1.0 | ||
| No | 46 (58.2) | 1 | |
| Yes | 10 (58.8) | 1.03 (0.35, 2.97) | |
| Statin use, n (%) | .038 | ||
| No | 4 (30.8) | 1 | |
| Yes | 52 (62.7) | 3.77 (1.07, 13.33) | |
*
n=96
HL—Hyperlipidemia
DM2—Diabetes mellitus, type 2
Notes:
1
The multivariable analysis selected a model containing statin use as the single predictor of LDL control at follow-up
2
Fisher’s exact test, except for age: likelihood ratio test of logistic regression
3
Comparing Hispanics and Caucasians only.